Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells

Sumati Gupta, S. Sharma, Alexis Weston et al.|Prostate Cancer and Prostatic Diseases|2016

Cited by 47